thalidomide
malignancies
Thalidomide
angiogenic
bFGF
IL-6
label
thalidomide
men
androgen
prostate cancer
prostate-specific antigen
PSA
urea
serum bFGF
men
serum
PSA
men
absolute PSA
serum bFGF
progressive disease
men
PSA
bFGF
men
PSA
growth
Adverse effects
constipation
dizziness
rash
withdrawal
men
peripheral sensory neuropathy
men
men
thalidomide
peripheral neuropathy
thalidomide
development
peripheral neuropathy
